807
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults

, , , , , & show all
Pages 1203-1215 | Accepted 01 Aug 2013, Published online: 23 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jadwiga Najib, Ekaterina Didenko, Daria Meleshkina, Kamila Yusupov, Kateryna Maw, Justin Ramnarain & Maliha Tabassum. (2020) Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder. Current Medical Research and Opinion 36:10, pages 1717-1735.
Read now
Timothy Wigal, Ann Childress, Glen Frick, Brian Yan, Sharon Wigal & Manisha Madhoo. (2018) Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment. Postgraduate Medicine 130:1, pages 111-121.
Read now
Alain Joseph, Martin Cloutier, Annie Guérin, Roy Nitulescu & Vanja Sikirica. (2016) Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine. Patient Preference and Adherence 10, pages 391-405.
Read now
Carlos Roncero & F Javier Álvarez. (2014) The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. Expert Review of Neurotherapeutics 14:8, pages 849-865.
Read now

Articles from other publishers (1)

Peter Greven, Vanja Sikirica, Yaozhu J. Chen, Tammy G. Curtice & Charles Makin. (2016) Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany. The European Journal of Health Economics 18:7, pages 893-904.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.